Superluminal Medicines offers drug discovery and development using generative biology, chemistry, and advanced machine learning. Their platform designs and tests highly selective compounds, targeting precise protein structures to create therapeutic breakthroughs. By combining deep biological expertise with proprietary big data infrastructure, accelerating the creation of candidate-ready drugs.
📋 Overview of Superluminal Medicines
Founding Year
2022
Estimated Funding
Size
$0000
Locations
Primary Industry
📙 About Superluminal Medicines
💰 Recent Investors of Superluminal Medicines
Catalio Capital Management, Cooley, Investor
🔁 Companies Similar to Superluminal Medicines
© 2025 Bot Memo. All Rights Reserved.
